So, back to the question
Last year, it sold about 6% for Rs 1,750 crore
Tirzepatide, a novel medication that mimics the action of two hormones involved in blood sugar regulation, has shown promising results in clinical trials, leading to significant weight loss and improved glycemic control among patients with type 2 diabetes
Robin Carlson, MSN, of Nebraska Spine Hospital for her invaluable help compiling resources
Diabetes Obes Metab (2011) 13(4):3747.10.1111/j.1463-1326.2010.01355.x 15 JensenLBKollerupGQuaadeFSorensenOH
Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, et al: Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease